Filter Results:
(117)
Show Results For
- All HBS Web (117)
- Faculty Publications (9)
Show Results For
- All HBS Web (117)
- Faculty Publications (9)
- 29 May 2001
- Research & Ideas
Genomics: Can We Start Making Money Now?
Now that scientists have mapped the human gene, can drug makers map a road to unlimited riches? For John Lechleiter, Executive Vice President of Eli Lilly and Company's Pharmaceutical Products and Corporate Development, there remain more... View Details
Keywords: by Sean Silverthorne
- Fast Answer
Biotech and Pharmaceuticals: R&D spending, production cost
Where to find biotech and pharmaceuticals R&D spending and product cost data? Bloomberg – use BI function to locate R&D spending data Cortellis - special database on pharmaceuticals industry including R&D... View Details
- 01 Sep 2004
- News
American Dream
visitors in their tracks. “I wonder if I should turn him down a little,” Hustead muses. As president of Wall Drug in Wall, South Dakota, Hustead ponders this and many other details of a 76,000-square-foot roadside attraction, not far from... View Details
- 18 Jul 2024
- Blog Post
Harvard Business School Announces Its 2024-2025 Blavatnik Fellows
positioning KiraGen Bio to create substantial value for all stakeholders. Stephen Linderman (MD, PhD 2019) is the CEO and co-founder of Absco Therapeutics (AbscoTx), an immune oncology company specializing in image-guided, intratumoral... View Details
- 10 Sep 2008
- Research & Ideas
Long-Tail Economics? Give Me Blockbusters!
you can make money in many creative industries by selling specialized products to niche markets identified via the Internet. For example, the new CEO of GlaxoSmithKline, the pharmaceuticals giant, likens the search for blockbusters to... View Details
- 01 Jun 2000
- News
The Business of Biotech
biotechnology. The prospect is exhilarating, but the road to this brave new biotech world has more than a few bumps. With an average time line of ten years required to bring a drug to market - and the potential for failure looming every... View Details
Keywords: Julia Hanna
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
coming of age of biotechnology. The disappearance of "blockbuster" drugs could create new management challenges for pharmaceutical companies. — Gary Pisano The prospect is exhilarating, but the road to this brave new biotech... View Details
- Student-Profile
Olivia Zhao
the social sciences were very appealing to me. Also, all the questions I found most interesting were being studied there by economists, so I wanted to learn how to use their methods to make meaning out of data. “As for why I chose to View Details
- 14 May 2014
- News
(Re)moving the Needle
You wouldn't think that the lowly, annoying mosquito would have anything to teach researchers working on the cutting edge of drug delivery methodology, but you would be wrong. Have you ever noticed that you don't become aware of a... View Details
- 01 Mar 2017
- News
Alumni Take Cold Calls in New York City
Alumni gathered in New York City in November for a dynamic case discussion — a special benefit for members of the HBS Fund Investors Society. John Quelch, the Charles Edward Wilson Professor of Business Administration at HBS, joined... View Details
- 01 Sep 2008
- News
In Africa, Porter Sees Lessons for Health Care
practices to understand principles,” Porter has said. As part of that effort, and emerging from his trip, Porter and several GHD colleagues have written a case study, “HIV Care in Rwanda,” that was the subject of a special seminar at HBS... View Details
- 07 Oct 2014
- News
Network Effect
Henry McCance, founder (left), and Tim Armour, President & CEO, of Cure Alzheimer's Fund Twelve years ago, when Henry McCance (MBA 1966) and his wife initially faced her diagnosis of Alzheimer’s disease, the couple consulted some of the world’s top physicians View Details
Keywords: Linda Kush
- Profile
Henry McCance
Twelve years ago, when Henry McCance (MBA 1966) and his wife initially faced her diagnosis of Alzheimer’s disease, the couple consulted some of the world’s top physicians specializing in its treatment. McCance was shocked by their advice.... View Details
- 01 Mar 2017
- News
How Deep Brain Stimulation Could Change Medicine
targeted approach gives Bennet hope that Harmoni can benefit not only people suffering from movement disorders, but also a whole class of psychiatric patients who, until now, had few options beyond prescription drugs to help lessen the... View Details
Keywords: Janelle Nanos
- 05 May 2020
- News
“Walking a Tightrope”
Kristof, most of which have focused on poverty in developing countries. But in the Pulitzer Prize-winning duo’s latest book, Tightrope: Americans Reaching for Hope, they turn their lens on working class communities in the United States—communities that have been... View Details
- 01 Jun 2018
- News
The Long Run
trajectory of overdose deaths from prescription drugs and heroin. According to the Centers for Disease Control and Prevention, the US death rate from opioid overdose has increased over 400 percent since 1999; the picture is even grimmer... View Details
- 12 Jul 2020
- Research & Ideas
Solving COVID'S Mental Health Crisis
for everyone and also highlighted the important link between research, discovery, and cure." The GPP is a statewide prevention program aimed at reducing the use of dangerous drugs among teens and young adults through awareness campaigns,... View Details
- 01 Mar 2009
- News
A New Approach to Health-Care Reform
companies, complete and accurate patient data would help in screening participants in drug trials and make it possible to track and troubleshoot unexpected problems that show up after a drug is introduced... View Details
- 22 Sep 2017
- News
The Epicenter of Miami’s Vice
Subscribe on iTunes Subscribe on SoundCloud More Skydeck episodes Dan Morrell: The dark neon of late 70s and early 80s Miami has long been one of pop culture's favorite settings, from Miami Vice to Grand Theft Auto. Roben Farzad (MBA 2005), author, Public Radio host,... View Details
- 08 Apr 2009
- Research & Ideas
Clayton Christensen on Disrupting Health Care
screening participants in drug trials and make it possible to track and troubleshoot unexpected problems that show up after a drug is introduced into the general population, like what happened with Vioxx.... View Details